Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)

Nov 28, 2016 by in CARDIOLOGY Comments Off on Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)

Recent American College of Cardiology/American Heart Association guidelines on statin initiation on the basis of total atherosclerotic cardiovascular disease risk argue that the preventive effect of statins on cardiovascular events…

read more

Medical Therapy and Coronary Revascularization for Patients With Stable Coronary Artery Disease and Unclassified Appropriateness Score

Nov 28, 2016 by in CARDIOLOGY Comments Off on Medical Therapy and Coronary Revascularization for Patients With Stable Coronary Artery Disease and Unclassified Appropriateness Score

Although the appropriate use criteria incorporate common clinical scenarios for coronary revascularization, a significant proportion of patients with stable coronary artery disease (CAD) cannot be assigned an appropriateness score. Our…

read more

Short-Term and Long-Term Outcomes After Polytetrafluoroethylene-Covered Stent Implantation for the Treatment of Coronary Perforation

Nov 28, 2016 by in CARDIOLOGY Comments Off on Short-Term and Long-Term Outcomes After Polytetrafluoroethylene-Covered Stent Implantation for the Treatment of Coronary Perforation

This study sought to evaluate the short-term and 3-year outcomes of polytetrafluoroethylene-covered stent (PCS) for patients with coronary perforation. Implantation of a PCS has improved the immediate clinical outcomes of…

read more

Comparison of Outcomes of Patients With ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention Analyzed by Age Groups (85 Years); (Results from the Bremen STEMI Registry)

Nov 28, 2016 by in CARDIOLOGY Comments Off on Comparison of Outcomes of Patients With ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention Analyzed by Age Groups (85 Years); (Results from the Bremen STEMI Registry)

As old patients, who were treated by percutaneous coronary interventions (PCI) for ST-segment elevation myocardial infarction (STEMI), are regularly excluded or underrepresented in randomized trials, data on treatment and outcomes…

read more

Impact of Nonalcoholic Fatty Liver Disease on Myocardial Perfusion in Nondiabetic Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Nov 28, 2016 by in CARDIOLOGY Comments Off on Impact of Nonalcoholic Fatty Liver Disease on Myocardial Perfusion in Nondiabetic Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Limited data exist on the role of nonalcoholic fatty liver disease (FLD) as a potential independent risk factor in the setting of acute coronary syndromes. The aim of this study…

read more

Myocardial Infarct Size in Patients on Long-Term Statin Therapy Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

Nov 28, 2016 by in CARDIOLOGY Comments Off on Myocardial Infarct Size in Patients on Long-Term Statin Therapy Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

Statin pretreatment has been reported to have a cardioprotective effect in patients undergoing elective or urgent percutaneous coronary intervention (PCI). However, data on patients with ST-elevation myocardial infarction (STEMI) undergoing…

read more

Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease

Nov 28, 2016 by in CARDIOLOGY Comments Off on Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease

Statins are extensively used to treat dyslipidemia, but, because of their low tolerability profile, they are discontinued in a significant proportion of patients. Ezetimibe and nutraceuticals have been introduced as…

read more

OP-093 Diagnostic Value of Horizontal ECG Method for Detecting St Segment Changes in Patients with Acute Anterolateral Myocardial İnfarction

Nov 27, 2016 by in CARDIOLOGY Comments Off on OP-093 Diagnostic Value of Horizontal ECG Method for Detecting St Segment Changes in Patients with Acute Anterolateral Myocardial İnfarction

Objective The aim of the present study is to compare the amount of ST segment elevation on horizontal electrocardiography (hECG) by placing standard precordial leads (V3-6) horizontally on the left…

read more

PP-053 Case Report Serious Embolization of Watchman Device After Percutaneous Closure of the Left Atrial Appendage in Patient with Previous Transcatheter Aortic Valve Implantation

Nov 27, 2016 by in CARDIOLOGY Comments Off on PP-053 Case Report Serious Embolization of Watchman Device After Percutaneous Closure of the Left Atrial Appendage in Patient with Previous Transcatheter Aortic Valve Implantation

Percutaneous watchman device closure of the left atrial appendage is an increasingly recognized procedure as a valid alternative to oral anticoagulation, especially in patients with contraindication to anticoagulant therapy or…

read more
Get Clinical Tree app for offline access